A Study of AARC Standards on Diagnosis and Treatment of Patients With HBV-ACLF in China (AARC China Study)
NCT04054037 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2019-08-13
Summary
The AARC China Study is to establish a widely recognized and harmonized standard of patients with HBV-ACLF in the Asia Pacific region.
Conditions
- Acute on Chronic Liver Failure
- HBV
Interventions
- OTHER
-
No intervention
This is an observation study, no intervention will be indicated during diagnosis and treatment.
Sponsors & Collaborators
-
Qin Ning
lead OTHER
Principal Investigators
-
Qin Ning, MD., PhD. · Department of Infectious Disease, Tongji Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-02
- Primary Completion
- 2022-04-01
- Completion
- 2023-04-01
Countries
- China
Study Locations
More Related Trials
-
Population-wide Research for HBV-related Liver Diseases in Maoming City
NCT06184347 ·Status: NOT_YET_RECRUITING
-
Observational Study on Patients With Chronic Hepatitis B
NCT02167503 ·Status: UNKNOWN
-
"Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
NCT03097952 ·Status: RECRUITING
-
Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon Treatment
NCT02348502 ·Status: UNKNOWN
-
Clinical Characteristics, Natural Outcome and Treatment Optimization of Refractory
NCT05376124 ·Status: RECRUITING
-
Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection
NCT02511743 ·Status: COMPLETED
-
Patients With Chronic Hepatitis B and Low Viremia Not Receiving Antiviral Therapy
NCT01090531 ·Status: UNKNOWN
-
A Multicenter Prospective Clinical Cohort Study on the Pathogen Spectrum of Severe Hepatitis (Liver Failure) Complicated With Infection
NCT06272071 ·Status: NOT_YET_RECRUITING
-
The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy
NCT01957618 ·Status: UNKNOWN
-
Study of the Model to Predict 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver Failure
NCT01826760 ·Status: COMPLETED
-
HELIO Liver Test Performance Study in China (HEPATIC)
NCT05053412 ·Status: COMPLETED
-
HBsAg Declined Patients Follow-up Study
NCT05977283 ·Status: RECRUITING
-
Mother-to-child Transmission of HBV in China
NCT05172453 ·Status: RECRUITING
-
Antibody Response to COVID-19 Vaccines in Liver Disease Patients
NCT04775069 ·Status: COMPLETED ·Phase: PHASE4
-
Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy
NCT02791386 ·Status: COMPLETED
-
Prospective Observational Study of Disease Progression in Chronic Hepatitis C
NCT02011932 ·Status: ACTIVE_NOT_RECRUITING
-
Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy
NCT05965388 ·Status: NOT_YET_RECRUITING
-
Research on the Monitoring, Pathogen Screening, and Diagnostic System for Unexplained and Newly Emerging Acute Hepatitis
NCT06653140 ·Status: NOT_YET_RECRUITING
-
Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines
NCT02601040 ·Status: COMPLETED ·Phase: PHASE4
-
Predictive Model for Prognosis of Chronic HBV Infection Mothers
NCT04805034 ·Status: UNKNOWN
-
Laboratory Profile of Hepatitis B and C in Users of a Reference Service
NCT00512941 ·Status: COMPLETED
-
Registry-based Study in Patients With Hepatitis D Virus (HDV) Infection in China
NCT05451082 ·Status: NOT_YET_RECRUITING
-
A Clinical Research on Disease Progression and Intervention of Chronic HepatitisB
NCT05057065 ·Status: UNKNOWN
-
Linkage to Care and Treatment of Chronic HBV Patients
NCT06658678 ·Status: COMPLETED ·Phase: NA
-
Epidemiological Survey of Hepatitis D Virus Infection in China
NCT04483518 ·Status: COMPLETED